Skip to main content
. 2017 Dec 5;7(12):e017917. doi: 10.1136/bmjopen-2017-017917

Figure 1.

Figure 1

Drugs included in transparency analysis. BLA, biologic license application; FDA, Food and Drug Administration; NDA, new drug application; NME, new molecular entities.